CELLIPSE co-founders are experienced scientists and professionals with complementary skill sets who came together on this venture with one goal in mind : offer first-in-class drugs to solve unmet medical needs in oncology.
Chief Executive Officer
BA from ESSEC and MBA from M.I.T. Sloan School of Management. Serial Entrepreneur and Business Developper, Fabrice was co-founder and CEO of Laboratoires Narval, acquired by the RESMED Group in 2009.
Dr Renaud Prudent
Chief Operating Officer
PhD in BioChemistry. Renaud is a specialist in kinase inhibitors and has significant experience in Intellectual Property assets development.
PhD in Biology, Directeur de Recherche CNRS at Institut Albert Bonniot. Laurence is studying for the past 20 years the function of the cytoskeleton in the pathophysiology of cancer. She is also a reknowkn expert in the fied of High Content Screening technology.